Skip to main content
logo
Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,730.00
0.00 (0.00%)
At close: Jul 31, 2026

Genesystem Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
647.07381.361,208897.033,653
Revenue Growth
-43.04%-68.42%34.64%-75.44%-
Gross Profit
-2,471-2,465-1,820-1,5861,167
Operating Income
-9,318-9,690-10,116-9,484-6,605
Net Income
-11,689-11,955-8,915-7,915-8,996
Earnings Per Share
-1713.16-1754.01-1302.00-1139.05-1303.50
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
5,1071,8747,69414,34826,489
Total Debt
3,9804,0454,1214,4884,095
Net Cash (Debt)
1,128-2,1723,5749,86022,394
Net Cash Growth
-17.29%--63.75%-55.97%-
Net Cash Per Share
165.31-318.62521.911418.863244.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-6,956-6,883-7,337-7,812-6,417
Capital Expenditures
-179.06-219.66-258.73-362.85-238.43
Free Cash Flow
-7,135-7,103-7,595-8,174-6,655
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
---150.69%-176.81%31.96%
Operating Margin
-1440.06%-2541.03%-837.58%-1057.33%-180.80%
Pretax Margin
-2394.09%-4172.23%-801.44%-882.09%-193.26%
Profit Margin
-1806.37%-3134.97%-738.17%-882.41%-246.26%
FCF Margin
-1102.68%-1862.60%-628.89%-911.27%-182.18%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Forward PE
-14.8514.8514.85-
PS Ratio
60.5773.3349.1572.6515.88